2192 Stock Overview
Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medlive Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$8.10 |
| 52 Week High | HK$17.24 |
| 52 Week Low | HK$5.59 |
| Beta | 0.76 |
| 1 Month Change | -5.70% |
| 3 Month Change | 11.72% |
| 1 Year Change | -26.09% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -73.87% |
Recent News & Updates
Recent updates
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 27
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Jul 10Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless
May 11Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)
May 02Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 26Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital
Feb 06There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital
Oct 31Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 14These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts
Apr 03Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?
Feb 22Shareholder Returns
| 2192 | HK Healthcare Services | HK Market | |
|---|---|---|---|
| 7D | -17.2% | -7.0% | -3.4% |
| 1Y | -26.1% | -25.9% | -13.1% |
Return vs Industry: 2192 underperformed the Hong Kong Healthcare Services industry which returned -24.2% over the past year.
Return vs Market: 2192 underperformed the Hong Kong Market which returned -10.1% over the past year.
Price Volatility
| 2192 volatility | |
|---|---|
| 2192 Average Weekly Movement | 7.6% |
| Healthcare Services Industry Average Movement | 7.5% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 14.3% |
| 10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 2192 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 2192's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 668 | Liping Tian | https://www.medlive.cn |
Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company’s medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies.
Medlive Technology Co., Ltd. Fundamentals Summary
| 2192 fundamental statistics | |
|---|---|
| Market Cap | HK$5.89b |
| Earnings (TTM) | HK$206.88m |
| Revenue (TTM) | HK$389.12m |
28.5x
P/E Ratio15.1x
P/S RatioIs 2192 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2192 income statement (TTM) | |
|---|---|
| Revenue | CN¥355.61m |
| Cost of Revenue | CN¥128.89m |
| Gross Profit | CN¥226.72m |
| Other Expenses | CN¥37.66m |
| Earnings | CN¥189.07m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.26 |
| Gross Margin | 63.76% |
| Net Profit Margin | 53.17% |
| Debt/Equity Ratio | 0% |
How did 2192 perform over the long term?
See historical performance and comparison